# EDGAR Filing Document

**Accession Number:** 0001355064
**File Stem:** 0001752724-23-046771
**Filing Date:** 2023-2
**Character Count:** 28782
**Document Hash:** 7ad7a8de403f2c692a0dadfe1088c6e9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-046771.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001752724-23-046771

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230228

**PERIOD START**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MUTUAL FUND SERIES TRUST
- **CENTRAL INDEX KEY:** 0001355064
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21872
- **FILM NUMBER:** 23683039

**BUSINESS ADDRESS:**
- **STREET 1:** C/O GEMINI FUND SERVICES LLC
- **STREET 2:** 4221 NORTH 203RD STREET, SUITE 100
- **CITY:** ELKHORN
- **STATE:** NE
- **ZIP:** 68022-3474
- **BUSINESS PHONE:** 631 549 1859

**MAIL ADDRESS:**
- **STREET 1:** C/O GEMINI FUND SERVICES LLC
- **STREET 2:** 4221 NORTH 203RD STREET, SUITE 100
- **CITY:** ELKHORN
- **STATE:** NE
- **ZIP:** 68022-3474

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CATALYST FUNDS
- **DATE OF NAME CHANGE:** 20060303

## Series and Classes Contracts Data

### AlphaCentric LifeSci Healthcare Fund (Series ID: S000067055)

| Class ID   | Class Name                                   | Ticker Symbol   |
|:---|:---|:---|
| C000215729 | AlphaCentric LifeSci Healthcare Fund Class C | LYFCX           |
| C000215730 | AlphaCentric LifeSci Healthcare Fund Class I | LYFIX           |
| C000215731 | AlphaCentric LifeSci Healthcare Fund Class A | LYFAX           |

## Nport-Ex

---

| | | |
|:---|:---|:---|
| **ALPHACENTRIC LIFESCI HEALTHCARE FUND** | **ALPHACENTRIC LIFESCI HEALTHCARE FUND** | **ALPHACENTRIC LIFESCI HEALTHCARE FUND** |
| **SCHEDULE OF INVESTMENTS (Unaudited)** | **SCHEDULE OF INVESTMENTS (Unaudited)** | **SCHEDULE OF INVESTMENTS (Unaudited)** |
| **December 31, 2022** | **December 31, 2022** | **December 31, 2022** |
| **Shares** |  | **Fair Value** |
|  | **COMMON STOCKS — 95.4%** |  |
|  | **BIOTECH & PHARMA - 76.8%** |  |
| 180000 | 2seventy bio, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; $1686600 |
| 50000 | ACADIA Pharmaceuticals, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 796000 |
| 297500 | ADC Therapeutics S.A.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1142400 |
| 500000 | Amarin Corp plc - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 605000 |
| 81000 | Amryt Pharma plc - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 591300 |
| 78500 | Arcutis Biotherapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1161800 |
| 352500 | Aurinia Pharmaceuticals, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1522800 |
| 125000 | BioCryst Pharmaceuticals, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1435000 |
| 15000 | Celldex Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 668550 |
| 70000 | CinCor Pharma, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 860300 |
| 187500 | Coherus Biosciences, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1485000 |
| 49500 | Collegium Pharmaceutical, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1148400 |
| 185000 | Columbia Care, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 138750 |
| 36000 | Dynavax Technologies Corporation<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 383040 |
| 102500 | Elanco Animal Health, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1252550 |
| 33000 | Exelixis, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 529320 |
| 42500 | Galapagos N.V. - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1886150 |
| 8500 | Gilead Sciences, Inc. | &nbsp;&nbsp;&nbsp; 729725 |
| 61000 | GSK plc - ADR | &nbsp;&nbsp;&nbsp; 2143540 |
| 25500 | Horizon Therapeutics plc<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 2901900 |
| 75000 | Innoviva, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 993750 |
| 20000 | Insmed, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 399600 |
| 7500 | Intra-Cellular Therapies, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 396900 |
| 3500 | Jazz Pharmaceuticals plc<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 557585 |
| 45000 | Kiniksa Pharmaceuticals Ltd.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 674100 |
| 14000 | Mirati Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 634340 |
| 185000 | MorphoSys A.G. - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 662300 |
| 105000 | Novavax, Inc., Class A<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1079400 |
| 15500 | Nuvalent, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 461590 |
| 325000 | Nuvation Bio, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 624000 |
| 19000 | Pacira BioSciences, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 733590 |
| 50000 | Puma Biotechnology, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 211500 |
| 20000 | Sanofi - ADR | &nbsp;&nbsp;&nbsp; 968600 |
| 90000 | Takeda Pharmaceutical Company Ltd. - ADR | &nbsp;&nbsp;&nbsp; 1404000 |

---

---

| | | |
|:---|:---|:---|
| **ALPHACENTRIC LIFESCI HEALTHCARE FUND** | **ALPHACENTRIC LIFESCI HEALTHCARE FUND** | **ALPHACENTRIC LIFESCI HEALTHCARE FUND** |
| **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** |
| **December 31, 2022** | **December 31, 2022** | **December 31, 2022** |
| **Shares** |  | **Fair Value** |
|  | **COMMON STOCKS — 95.4% (Continued)** |  |
|  | **BIOTECH & PHARMA - 76.8% (Continued)** |  |
| 27500 | Taro Pharmaceutical Industries Ltd.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; $798600 |
| 18640 | Travere Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 391999 |
| 27000 | Ultragenyx Pharmaceutical, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1250910 |
| 2250 | United Therapeutics Corporation<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 625703 |
| 55000 | Verona Pharma plc - ADR<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1437150 |
| 35500 | Viridian Therapeutics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1036955 |
| 52500 | Zymeworks, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 412650 |
|  |  | &nbsp;&nbsp; 38823347 |
|  | **CONSUMER SERVICES - 2.6%** |  |
| 360000 | AirSculpt Technologies, Inc. | &nbsp;&nbsp;&nbsp; 1332000 |
|  | **HEALTH CARE FACILITIES & SERVICES - 5.2%** |  |
| 842000 | Aveanna Healthcare Holdings, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 656760 |
| 110000 | DocGo, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 777700 |
| 39500 | Fulgent Genetics, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1176310 |
|  |  | &nbsp;&nbsp; 2610770 |
|  | **MEDICAL EQUIPMENT & DEVICES - 8.2%** |  |
| 3400 | Bio-Rad Laboratories, Inc., Class A<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1429666 |
| 5000 | Embecta Corporation | &nbsp;&nbsp;&nbsp; 126450 |
| 10000 | Inmode Ltd.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 357000 |
| 17000 | Lantheus Holdings, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 866320 |
| 4000 | Medtronic plc | &nbsp;&nbsp;&nbsp; 310880 |
| 415000 | SomaLogic, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 1041650 |
|  |  | &nbsp;&nbsp; 4131966 |
|  | **RETAIL - CONSUMER STAPLES - 2.6%** |  |
| 95000 | PetIQ, Inc.<sup>(a)</sup> | &nbsp;&nbsp;&nbsp; 875900 |
| 12000 | Walgreens Boots Alliance, Inc. | &nbsp;&nbsp;&nbsp; 448320 |
|  |  | &nbsp;&nbsp; 1324220 |
|  | **TOTAL COMMON STOCKS (Cost $51,715,320)** | &nbsp;&nbsp; 48222303 |

---

---

| | | |
|:---|:---|:---|
| **ALPHACENTRIC LIFESCI HEALTHCARE FUND** | **ALPHACENTRIC LIFESCI HEALTHCARE FUND** | **ALPHACENTRIC LIFESCI HEALTHCARE FUND** |
| **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** | **SCHEDULE OF INVESTMENTS (Unaudited) (Continued)** |
| **December 31, 2022** | **December 31, 2022** | **December 31, 2022** |
| **Shares** |  | **Fair Value** |
|  | **PREFERRED STOCKS** — **0.6%** |  |
|  | **BIOTECH & PHARMA** — **0.6%** |  |
| 3000 | VYNE Therapeutics Inc.<sup>(a) (d)</sup> **(Cost $300,000)** | &nbsp;&nbsp;&nbsp; $300000 |
|  | **MONEY MARKET FUNDS - 0.0% <sup>(b)</sup>** |  |
| 1 | Fidelity Government Portfolio Institutional Class, 4.06% (Cost $1)<sup>(c)</sup> | &nbsp;&nbsp;&nbsp; 1 |
|  | **TOTAL INVESTMENTS - 96.0% (Cost $52,015,321)** | &nbsp;&nbsp;&nbsp; $48522304 |
|  | **OTHER ASSETS IN EXCESS OF LIABILITIES - 4.0%** | &nbsp;&nbsp; 2002589 |
|  | **NET ASSETS - 100.0%** | &nbsp;&nbsp; $50524893 |

---

---

| | |
|:---|:---|
| ADR | - American Depositary Receipt |
| LTD | - Limited Company |
| NV | - Naamioze Vennootschap |
| PLC | - Public Limited Company |
| S/A | - Société Anonyme |
| <sup>(a)</sup> | - Non-income producing security. |
| <sup>(b)</sup> | - Percentage rounds to less than 0.1%. |
| <sup>(c)</sup> | - Rate disclosed is the seven day effective yield as of December 31, 2022. |
| <sup>(d)</sup> | - The value of this security has been determined in good faith under policies of the Board of Trustees.<br>|

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** MUTUAL FUND SERIES TRUST

- **b. Investment Company Act file number:** 811-21872

- **c. CIK number of Registrant:** 0001355064

- **d. LEI of Registrant:** 5493002ZGLQMLR4QMA96

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** C/O GEMINI FUND SERVICES LLC

  - **City:** ELKHORN

  - **State:** NE

  - **Foreign country:** US

  - **Zip / Postal Code:** 68022

  - **Telephone number:** 631-470-2600

**Item A.2. Information about the Series.**

- **a. Name of Series:** AlphaCentric LifeSci Healthcare Fund

- **b. EDGAR series identifier (if any):** S000067055

- **c. LEI of Series:** 549300XV4TMPQ6UX8179

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-03-31

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $50813893.49

**Total Liabilities:** $289000.68

**Net Assets:** $50524892.81

**Cash Not Reported:** $34966.32

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000215729 | 4.82%                | 5.27%                | 1.29%                |
| Class ID C000215731 | 4.95%                | 5.30%                | 1.36%                |
| Class ID C000215730 | 4.94%                | 5.36%                | 1.43%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-451236.62              | $2472766.44                                |
| Month 2  | $-1559745.25             | $4120398.15                                |
| Month 3  | $-1518209.98             | $2209414.70                                |

### Schedule of Portfolio Investments

| Name                                   | Title                     | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| PetIQ Inc.                             | PETIQ INC                 | CUSIP: 71639T106<br>LEI: 549300GROACFGKVYOX14 | Long             | EC               | CORP              | US        |     95000 | NS      | $875900.00    | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi                                 | SANOFI-ADR                | CUSIP: 80105N105<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |     20000 | NS      | $968600.00    | 1.92%             |  |  |  | No            |                  1 | On Loan: No      |
| Novavax Inc                            | NOVAVAX INC               | CUSIP: 670002401<br>LEI: 529900J4GJHPEPQ23205 | Long             | EC               | CORP              | US        |    105000 | NS      | $1079400.00   | 2.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Verona Pharma Plc                      | VERONA PHARMA PLC - ADR   | CUSIP: 925050106<br>LEI: 213800EVI6O6J3TIAL06 | Long             | EC               | CORP              | GB        |     55000 | NS      | $1437150.00   | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| AirSculpt Technologies Inc.            | AIRSCULPT TECHNO          | CUSIP: 009496100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    360000 | NS      | $1332000.00   | 2.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                           | NUVALENT INC-A            | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15500 | NS      | $461590.00    | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Kiniksa Pharmaceuticals Ltd.           | KINIKSA PHARMACEUTICALS-A | CUSIP: G5269C101<br>LEI: N/A                  | Long             | EC               | CORP              | BM        |     45000 | NS      | $674100.00    | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK plc                                | GSK PLC-ADR               | CUSIP: 37733W204<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |     61000 | NS      | $2143540.00   | 4.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Acadia Pharmaceuticals Inc             | ACADIA PHARMACEU          | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |     50000 | NS      | $796000.00    | 1.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Puma Biotechnology Inc                 | PUMA BIOTECHNOLOGY INC    | CUSIP: 74587V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     50000 | NS      | $211500.00    | 0.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                          | MEDTRONIC PLC             | CUSIP: G5960L103<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |      4000 | NS      | $310880.00    | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Viridian Therapeutics Inc              | VIRIDIAN THERAPE          | CUSIP: 92790C104<br>LEI: 549300C775BNYF550E70 | Long             | EC               | CORP              | US        |     35500 | NS      | $1036955.00   | 2.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences, Inc.                  | GILEAD SCIENCES           | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      8500 | NS      | $729725.00    | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Horizon Therapeutics PLC               | HORIZON THERAPEU          | CUSIP: G46188101<br>LEI: 529900P0GSQ79OOZEV53 | Long             | EC               | CORP              | IE        |     25500 | NS      | $2901900.00   | 5.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Fulgent Genetics Inc                   | FULGENT GENETICS INC      | CUSIP: 359664109<br>LEI: 549300CL6P01M68QJ404 | Long             | EC               | CORP              | US        |     39500 | NS      | $1176310.00   | 2.33%             |  |  |  | No            |                  1 | On Loan: No      |
| ADC Therapeutics SA                    | ADC THERAPEUTICS SA       | CUSIP: H0036K147<br>LEI: N/A                  | Long             | EC               | CORP              | CH        |    297500 | NS      | $1142400.00   | 2.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Embecta Corp.                          | EMBECTA CORP              | CUSIP: 29082K105<br>LEI: 549300RPG8GXVDHNXZ62 | Long             | EC               | CORP              | US        |      5000 | NS      | $126450.00    | 0.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Rad Laboratories, Inc.             | BIO-RAD LABS-A            | CUSIP: 090572207<br>LEI: 549300ZC1GPV35XYDK53 | Long             | EC               | CORP              | US        |      3400 | NS      | $1429666.00   | 2.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Amryt Pharma PLC (NEW)                 | AMRYT PHAR - ADR          | CUSIP: 03217L106<br>LEI: 213800YNUJEOJ84L4T95 | Long             | EC               | CORP              | GB        |     81000 | NS      | $591300.00    | 1.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Cincor Pharma Inc                      | CINCOR PHARMA IN          | CUSIP: 17240Y109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70000 | NS      | $860300.00    | 1.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc               | ELANCO ANIMAL HEALTH INC  | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |    102500 | NS      | $1252550.00   | 2.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirati Therapeutics Inc                | MIRATI THERAPEUT          | CUSIP: 60468T105<br>LEI: 529900GYRW59IDQV6N54 | Long             | EC               | CORP              | US        |     14000 | NS      | $634340.00    | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corporation        | UNITED THERAPEUT          | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |      2250 | NS      | $625702.50    | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Takeda Pharmaceutical Co Ltd.          | TAKEDA PHARM-ADR          | CUSIP: 874060205<br>LEI: 549300ZLMVP4X0OGR454 | Long             | EC               | CORP              | JP        |     90000 | NS      | $1404000.00   | 2.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Inmode Limited                         | INMODE LTD                | CUSIP: M5425M103<br>LEI: 984500DD95A35E9BD358 | Long             | EC               | CORP              | IL        |     10000 | NS      | $357000.00    | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Aurinia Pharmaceuticals Inc            | AURINIA PHARMACE          | CUSIP: 05156V102<br>LEI: 5299008YP2BW4570ML28 | Long             | EC               | CORP              | CA        |    352500 | NS      | $1522800.00   | 3.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Coherus Biosciences Inc                | COHERUS BIOSCIEN          | CUSIP: 19249H103<br>LEI: 5493007IL8W5MV932D26 | Long             | EC               | CORP              | US        |    187500 | NS      | $1485000.00   | 2.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Taro Pharmaceutical Industries Ltd.    | TARO PHARMACEUTICAL INDUS | CUSIP: M8737E108<br>LEI: 5493002WIJCSC2L2VL79 | Long             | EC               | CORP              | IL        |     27500 | NS      | $798600.00    | 1.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira Biosciences Inc                 | PACIRA BIOSCIENC          | CUSIP: 695127100<br>LEI: 549300P56LERYBDHCF69 | Long             | EC               | CORP              | US        |     19000 | NS      | $733590.00    | 1.45%             |  |  |  | No            |                  1 | On Loan: No      |
| 2seventy Bio Inc.                      | 2SEVENTY BIO-W/I          | CUSIP: 901384107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    180000 | NS      | $1686600.00   | 3.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Somalogic Inc.                         | SOMALOGIC INC             | CUSIP: 83444K105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    415000 | NS      | $1041650.00   | 2.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Amarin Corp                            | AMARIN CORP -ADR          | CUSIP: 023111206<br>LEI: 5493009JFIGUFEVPK217 | Long             | EC               | CORP              | GB        |    500000 | NS      | $605000.00    | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                       | NUVATION BIO INC          | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    325000 | NS      | $624000.00    | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| US BANK MMDA                           | US BANK MMDA-USBGFS 5     | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             |  | US        |   2084349 | PA      | $2084349.09   | 4.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis, Inc.                         | EXELIXIS INC              | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |     33000 | NS      | $529320.00    | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                           | INNOVIVA INC              | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |     75000 | NS      | $993750.00    | 1.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc               | TRAVERE THERAPEU          | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     18640 | NS      | $391999.20    | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Lantheus Holdings Inc                  | LANTHEUS HOLDING          | CUSIP: 516544103<br>LEI: 5299005HUB5IOJGO7S39 | Long             | EC               | CORP              | US        |     17000 | NS      | $866320.00    | 1.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Zymeworks Inc                          | ZYMEWORKS INC             | CUSIP: 98985Y108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     52500 | NS      | $412650.00    | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Docgo Inc                              | DOCGO INC                 | CUSIP: 256086109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    110000 | NS      | $777700.00    | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Dynavax Technologies Corp.             | DYNAVAX TECHNOLOGIES CORP | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |     36000 | NS      | $383040.00    | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Fidelity Institutional Cash Portfolios | FID-MM GOVT-I             | CUSIP: 316175108<br>LEI: 549300SHPEJB1OPRCV46 | Long             | STIV             | RF                | US        |         1 | PA      | $1.29         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Galapagos NV                           | GALAPAGOS NV-ADR          | CUSIP: 36315X101<br>LEI: 549300QKJ78IY0IOV655 | Long             | EC               | CORP              | BE        |     42500 | NS      | $1886150.00   | 3.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Columbia Care Inc                      | COLUMBIA CARE IN          | CUSIP: 197309107<br>LEI: 54930058IQZHXZUH2W23 | Long             | EC               | CORP              | CA        |    185000 | NS      | $138750.00    | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Aveanna Healthcare Holdings Inc        | AVEANNA HEALTHCA          | CUSIP: 05356F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    842000 | NS      | $656760.00    | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                             | INSMED INC                | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     20000 | NS      | $399600.00    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| VYNETP                                 | VYNE THERA PREF           | CUSIP: N/A<br>LEI: N/A                        | Long             | EP               | CORP              | US        |      3000 | NS      | $300000.00    | 0.59%             |  |  |  | Yes           |                  1 | On Loan: No      |
| BioCryst Pharmaceuticals  Inc.         | BIOCRYST PHARMACEUTICALS  | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |    125000 | NS      | $1435000.00   | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Walgreens Boots Alliance, Inc.         | WALGREENS BOOTS           | CUSIP: 931427108<br>LEI: 549300RPTUOIXG4LIH86 | Long             | EC               | CORP              | US        |     12000 | NS      | $448320.00    | 0.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Ultragenyx Pharmaceuticals Inc         | ULTRAGENYX PHARM          | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |     27000 | NS      | $1250910.00   | 2.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Incorporation  | ARCUTIS BIOTHERAPEUTICS I | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78500 | NS      | $1161800.00   | 2.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC               | JAZZ PHARMACEUTI          | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |      3500 | NS      | $557585.00    | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| MorphoSys AG                           | MORPHOSYS AG ADR          | CUSIP: 617760202<br>LEI: 529900493806K77LRE72 | Long             | EC               | CORP              | DE        |    185000 | NS      | $662300.00    | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Intra-Cellular Therapies Inc           | INTRA-CELLULAR THERAPIES  | CUSIP: 46116X101<br>LEI: 5299002U2KGF193IJA20 | Long             | EC               | CORP              | US        |      7500 | NS      | $396900.00    | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Celldex Therapeutics Inc.              | CELLDEX THERAPEU          | CUSIP: 15117B202<br>LEI: 529900F018DMYWH38923 | Long             | EC               | CORP              | US        |     15000 | NS      | $668550.00    | 1.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc.          | COLLEGIUM PHARMA          | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |     49500 | NS      | $1148400.00   | 2.27%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-01-27

**Name of Applicant:** MUTUAL FUND SERIES TRUST

**Signature:** Erik Naviloff

**Name of Signer:** Erik Naviloff

**Title:** Treasurer